calcium chloride
Trade name: calcium chloride
Approved
Dec 7, 1953
Calcium chloride is an inorganic compound, a salt with the chemical formula CaCl2. It is a white crystalline solid at room temperature, and it is highly soluble in water. It can be created by neutralising hydrochloric acid with calcium hydroxide. — Wikipedia
Clinical trial activity
26 trials · 27 clinical orgs · 46 marketing orgs
Earliest trial started Jun 1, 2006 (NCT00378872)
Timeline
1940s
- Jun 1, 1941
Evidence of US Marketing
1950s
- Dec 7, 1953
Earliest FDA Approval
- Dec 7, 1953
Strides Pharma Science — Marketing Organization
- Dec 7, 1953
DAVA Pharmaceuticals — Marketing Organization
1970s
- Mar 22, 1971
Baxter — First NDA Organization
- Mar 22, 1971
Baxalta — Marketing Organization
- Mar 22, 1971
Baxter — NDA Secondary Org
- Mar 22, 1971
Baxter — NDA Organization
- Aug 13, 1975
ICU Medical Inc — Marketing Organization
- Aug 13, 1975
ICU Medical Inc — NDA Secondary Org
- Feb 8, 1978
B. Braun — Marketing Organization
- Feb 8, 1978
B. Braun — NDA Secondary Org
- Sep 5, 1979
Bristol-Myers — Marketing Organization
1980s
- Jan 15, 1980
Hospira — NDA Secondary Org
- Oct 28, 1981
Nestle — NDA Secondary Org
- Feb 14, 1985
Bristol-Myers Squibb — Marketing Organization
- May 9, 1986
Norbrook — Marketing Organization
- Jun 13, 1986
Abraxis — Marketing Organization
- Sep 16, 1986
West-Ward Pharmaceutical — Marketing Organization
- Nov 7, 1988
Hospira — Marketing Organization
1990s
- Oct 15, 1990
Barr Laboratories — Marketing Organization
- Aug 23, 1991
Pharmacia & Upjohn — Marketing Organization
- Nov 27, 1991
Akorn, Inc. — Marketing Organization
- Nov 27, 1991
Akorn, Inc. — NDA Secondary Org
- Nov 27, 1991
Epic Pharma Llc — NDA Secondary Org
- May 15, 1992
Mylan — Marketing Organization
- Jun 13, 1994
Fresenius — Marketing Organization
- Aug 1, 1994
Hikma — Marketing Organization
- Sep 27, 1996
Lukare Medical — Marketing Organization
- Sep 27, 1996
Lukare Medical — NDA Secondary Org
- Jun 17, 1999
Duramed Research — Marketing Organization
2000s
2010s
- Jan 8, 2010
Pharmachemie Bv — Marketing Organization
- Mar 29, 2012
EXTROVIS — Marketing Organization
- Jan 1, 2013
Earliest Phase 1 Sponsor(trial)
- Jan 1, 2014
Earliest Phase 3 Sponsor(trial)
- Aug 25, 2014
Fresenius — NDA Secondary Org
- May 21, 2015
Sun Pharmaceuticals — Marketing Organization
- Jan 13, 2017
Zydus Discovery DMCC — Marketing Organization
- Apr 25, 2017
Silvergate Pharmaceuticals — Marketing Organization
- Apr 25, 2017
Azurity — Marketing Organization
- Jul 27, 2017
Lutipold — Marketing Organization
- Jul 27, 2017
Sankyo — Marketing Organization
- Jul 27, 2017
Daiichi Sankyo — Marketing Organization
- Dec 22, 2017
Amneal Pharmaceuticals — Marketing Organization
- May 9, 2018
International Medication — Marketing Organization
- Aug 9, 2018
Sagent Pharmaceuticals, Inc. — Marketing Organization
- May 1, 2019
Medefil — Marketing Organization
2020s
- Jan 30, 2020
Eugia Pharma — Marketing Organization
- Apr 23, 2021
Lotus Pharmaceutical — Marketing Organization
- Aug 7, 2023
Daito Pharmaceuticals — Marketing Organization
- May 16, 2024
Elite Laboratories, Inc — Marketing Organization
- Jun 3, 2024
Alembic — Marketing Organization
- Dec 17, 2024
Somerset Pharmaceuticals — Marketing Organization
Indications
Studied for
- Acid-Base Imbalance · Phase 3
- Alcoholic Intoxication · Phase 4
- Atrial Fibrillation · Phase 3
- Basal Cell Carcinoma · Phase 3
- Behcet Syndrome · Phase 4
- Body Fluids · Phase 4
- Burns · Phase 4
- Cardiopulmonary Bypass · Phase 4
- Cesarean Section · Phase 3
- Emergencies · Phase 4
- General Surgery · Phase 1/Phase 2
- Head and Neck Neoplasms · Phase 1
- Healthy Volunteers · Early Phase 1
- Heart Failure, Diastolic · Phase 4
- Hemorrhage · Phase 3
- Hemostasis · Phase 1/Phase 2
- Hyperlactatemia · Early Phase 1
- Hypocalcemia · Early Phase 1
- Keloid · Phase 1
- Osteoporosis · Early Phase 1
- Out-of-Hospital Cardiac Arrest · Phase 2
- Parturition · Early Phase 1
- Peritonitis · Phase 4
- Pneumonia · Phase 4
- Postpartum Hemorrhage · Phase 3
- Pregnancy Complications · Early Phase 1
- Sepsis · Phase 4
- Squamous Cell Carcinoma of Head and Neck · Phase 2
- Thoracic Surgery · Phase 4
- Uterine Inertia · Phase 3
- Vascular Diseases · Early Phase 1
- Xerostomia · Phase 2/Phase 3
Mechanism of action
- CalciumSupplementation
Calcium supplementation
Combination products
acetated ringer's
aminosyn ii w/ electrolytes in dextrose w/ calcium
with potassium chloride, amino acids, sodium chloride, potassium phosphate, glucose monohydrate, magnesium
bss plus
with potassium chloride, sodium bicarbonate, sodium phosphate, sodium chloride, glucose monohydrate, glutathione, magnesium
Also known as methotrexate sodium
clinimix e 4.25/25 sulfite free w/ elect in dextrose w/ calcium
with sodium acetate, amino acids, sodium chloride, potassium phosphate, glucose monohydrate, magnesium
Also known as clinimix e 2.75/10 sulfite free w/ elect in dextrose w/ calcium, clinimix e 2.75/25 sulfite free w/ elect in dextrose w/ calcium, clinimix e 2.75/5 sulfite free w/ elect in dextrose w/ calcium, clinimix e 4.25/10 sulfite free w/ elect in dextrose w/ calcium, clinimix e 4.25/20 sulfite free w/ elect in dextrose w/ calcium, clinimix e 4.25/5 sulfite free w/ elect in dextrose w/ calcium, clinimix e 5/10 sulfite free w/ elect in dextrose w/ calcium, clinimix e 5/15 sulfite free w/ elect in dextrose w/ calcium, clinimix e 5/20 sulfite free w/ elect in dextrose w/ calcium, clinimix e 5/25 sulfite free w/ elect in dextrose w/ calcium, clinimix e 5/35 sulfite free w/ elect in dextrose w/ calcium
dextrose in acetated ringer's
with potassium chloride, sodium acetate, sodium chloride, glucose monohydrate
dextrose in ringer's
with potassium chloride, sodium chloride, glucose monohydrate
Also known as dextrose and ringer's
dialyte w/ dextrose
with sodium acetate, sodium chloride, glucose monohydrate, magnesium
Also known as dialyte concentrate w/ dextrose
dianeal low calcium w/dextrose
with lactic acid, sodium chloride, glucose monohydrate, magnesium
Also known as delflex-lm w/ dextrose, delflex w/ dextrose, delflex w/ dextrose low magnesium, delflex w/ dextrose low magnesium low calcium, dianeal 137 w/ dextrose, dianeal low calcium w/ dextrose, dianeal pd-1 w/ dextrose, dianeal pd-2 w/ dextrose, inpersol-lc/lm w/ dextrose
elliotts b solution
with potassium chloride, magnesium sulfate, sodium bicarbonate, sodium phosphate, sodium chloride, glucose monohydrate
inpersol-zm w/ dextrose
isolyte e
with sodium citrate, potassium chloride, sodium acetate, sodium chloride, magnesium
Also known as balanced salt, bss
isolyte e w/ dextrose
with sodium citrate, potassium chloride, sodium acetate, sodium chloride, glucose monohydrate, magnesium
Also known as isolyte e in dextrose
isolyte r w/ dextrose
with potassium chloride, sodium acetate, sodium chloride, glucose monohydrate, magnesium
Also known as isolyte r in dextrose
kabiven
with soybean oil, potassium chloride, magnesium sulfate, sodium acetate, amino acids, sodium glycerophosphate pentahydrate, glucose monohydrate
Also known as perikabiven
lactated ringer's
lactated ringer's and dextrose
with potassium chloride, lactic acid, sodium chloride, glucose monohydrate
Also known as dextrose and lactated ringer's, dextrose in half-strength lactated ringer's, dextrose in lactated ringer's, dextrose in modified lactated ringer's, potassium chloride in dextrose and lactated ringer's
navstel
with potassium chloride, sodium bicarbonate, sodium phosphate, sodium chloride, oxiglutatione, glucose monohydrate, magnesium
phoxillum bk
with potassium chloride, sodium bicarbonate, sodium phosphate, sodium chloride, magnesium
Also known as phoxillum b22k
plasma-lyte m and dextrose
with potassium chloride, sodium acetate, lactic acid, sodium chloride, glucose monohydrate, magnesium
plasma-lyte r
with potassium chloride, sodium acetate, lactic acid, sodium chloride, magnesium
plegisol
with potassium chloride, sodium chloride, magnesium
Also known as cardioplegic
prismasol bk
with potassium chloride, lactic acid, sodium bicarbonate, sodium chloride, glucose monohydrate, magnesium
Also known as prismasol b22gk, prismasol bgk
ringer's
tpn electrolytes
with potassium chloride, sodium acetate, sodium chloride, magnesium
Approval history
- approvedPriority reviewDec 7, 1953
- approvedJun 1, 1941
Chemistry & pharmacology
SMILES
[Ca+2].[Cl-].[Cl-]- Mol. weight
- 110.98 g/mol
- Chirality
- Achiral Molecule
- Inorganic
- Yes
- Polymer
- No
- Delivery
- Parenteral
- Availability
- Prescription Only
Oral
No
Parenteral
Yes
Topical
No
Sources
- WikipediaCalcium chloride ↗
- ChEMBLCHEMBL1200668 ↗
Also known as
- calcium(2+) chloride
- calcium chloride
- calcium chloride
- calcium chloride
- calcium chloride
- calcium chloride
- calcium chloride
- calcium chloride
- calcium chloride
- calcium chloride
- calcium chloride anhydrous
- calcium chloride anhydrous
- calcium chloride, anhydrous
- calcium chloride, anhydrous
- calcium chloride dihydrate
- calcium chloride dihydrate
- cal plus
- cal plus
- e509
- e509
- glandosane
- hypozalix
- ringerfundin
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07187544 | N/A | Sep 30, 2025 | Icahn School of Medicine at Mount Sinai, Mount Sinai Hospital, Canada |
| NCT06378021 | Phase 3 | Mar 14, 2024 | Helwan University, Istanbul University |
| NCT05973747 | Early Phase 1 (Phase 1) | Sep 1, 2023 | Stanford University |
| NCT05027048 | Phase 3 | Jan 31, 2023 | Stanford University |
| NCT04660721 | Phase 1/Phase 2 (Phase 2) | Dec 31, 2020 | Sealantium Medical Ltd. |
| NCT04153435 | Phase 2 | Jan 31, 2020 | Aarhus University, Central Denmark Region |
| NCT05046262 | Phase 3 | Jan 8, 2020 | Mirai Medical, Ireland, University of Copenhagen |
| NCT04713319 | Early Phase 1 (Phase 1) | Oct 4, 2019 | Replicon Health Oy, University of Jyvaskyla |
| NCT03867383 | Phase 1/Phase 2 (Phase 2) | Mar 15, 2019 | Stanford University |
| NCT03772990 | Phase 4 | Jan 14, 2019 | Moscow State University, Vita-Salute University of Milano. Italy |
| NCT03719001 | Early Phase 1 (Phase 1) | Oct 23, 2018 | University of California, San Francisco |
| NCT03771170 | Phase 4 | Jan 10, 2018 | Yuria-Pharm |
| NCT03824457 | Phase 4 | Jan 8, 2018 | Yuria-Pharm |
| NCT03133767 | Phase 4 | May 1, 2017 | University of Iowa |
| NCT04152096 | Phase 4 | Jan 24, 2017 | Yuria-Pharm |
| NCT02950753 | Early Phase 1 (Phase 1) | Jan 4, 2017 | University Medical Center of Southern Nevada |
| NCT03764085 | Phase 4 | Dec 6, 2016 | Yuria-Pharm |
| NCT03051269 | Phase 1 | May 1, 2016 | University of Copenhagen |
| NCT02580604 | Early Phase 1 (Phase 1) | Nov 1, 2015 | University of Colorado, Denver |
| NCT02461329 | N/A | May 1, 2015 | Masaryk University, University Hospital Brno |
Organizations
Research & Development (27)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Yuria-Pharm | For profit | 4 | 4 | 1 | 2016 |
| Stanford University | Academic/Hospital | 3 | 3 | 3 | 2019 |
| University of Copenhagen | Academic/Hospital | 3 | 3 | 2 | 2013 |
| Aarhus University | Academic/Hospital | 1 | 1 | 1 | 2020 |
| Central Denmark Region | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Harvard University | Academic/Hospital | 1 | 1 | 1 | 2009 |
| Helwan University | Academic/Hospital | 1 | 1 | 1 | 2024 |
| Humboldt University | Academic/Hospital | 1 | 1 | 1 | 2009 |
| Icahn School of Medicine at Mount Sinai | Academic/Hospital | 1 | 1 | 1 | 2025 |
| Istanbul University | Academic/Hospital | 1 | 0 | 1 | 2024 |
| Masaryk University | Academic/Hospital | 1 | 0 | 1 | 2015 |
| Mirai Medical, Ireland | Academic/Hospital | 1 | 0 | 1 | 2020 |
| Moscow State University | Academic/Hospital | 1 | 1 | 1 | 2019 |
| Mount Sinai Hospital, Canada | Academic/Hospital | 1 | 0 | 1 | 2025 |
| Palacky University | Academic/Hospital | 1 | 1 | 1 | 2014 |
| Replicon Health Oy | Academic/Hospital | 1 | 1 | 1 | 2019 |
| Sealantium Medical Ltd. | For profit | 1 | 1 | 1 | 2020 |
| Shahid Beheshti University of Medical Sciences | Academic/Hospital | 1 | 0 | 1 | 2015 |
| University Hospital Brno | Academic/Hospital | 1 | 1 | 1 | 2015 |
| University Medical Center of Southern Nevada | Academic/Hospital | 1 | 1 | 1 | 2017 |
Marketing (65)
| Organization | Org type | Relationship | Date |
|---|---|---|---|
| Abbott | For profit | NDA2 | — |
| Abraxis | For profit | MKTG | Jun 13, 1986 |
| Accord Research | For profit | MKTG | Apr 30, 2007 |
| Akorn, Inc. | For profit | MKTG | Nov 27, 1991 |
| Akorn, Inc. | For profit | NDA2 | Nov 27, 1991 |
| Alcon | For profit | MKTG | Jul 24, 2008 |
| Alcon | For profit | SYN | Oct 28, 1981 |
| Alembic | For profit | MKTG | Jun 3, 2024 |
| Amneal Pharmaceuticals | For profit | MKTG | Dec 22, 2017 |
| Amneal Pharmaceuticals | For profit | SYN | Jul 8, 2024 |
| Azurity | For profit | MKTG | Apr 25, 2017 |
| B. Braun | For profit | MKTG | Feb 8, 1978 |
| B. Braun | For profit | NDA2 | Feb 8, 1978 |
| Barr Laboratories | For profit | MKTG | Oct 15, 1990 |
| Baxalta | For profit | SYN | Oct 25, 2006 |
| Baxalta | For profit | MKTG | Mar 22, 1971 |
| Baxalta | For profit | NDA2 | Oct 25, 2006 |
| Baxter | For profit | NDA2 | Mar 22, 1971 |
| Baxter | For profit | MKTG | Apr 21, 2000 |
| Baxter | For profit | NDA | Mar 22, 1971 |
| Bristol-Myers | For profit | MKTG | Sep 5, 1979 |
| Bristol-Myers Squibb | For profit | MKTG | Feb 14, 1985 |
| Bristol-Myers Squibb | For profit | SYN | Apr 14, 1989 |
| DAVA Pharmaceuticals | For profit | MKTG | Dec 7, 1953 |
| Daiichi Sankyo | For profit | MKTG | Jul 27, 2017 |
| Daito Pharmaceuticals | For profit | MKTG | Aug 7, 2023 |
| Duramed Research | For profit | MKTG | Jun 17, 1999 |
| EXTROVIS | For profit | MKTG | Mar 29, 2012 |
| Elite Laboratories, Inc | For profit | MKTG | May 16, 2024 |
| Epic Pharma Llc | For profit | NDA2 | Nov 27, 1991 |
| Eugia Pharma | For profit | MKTG | Jan 30, 2020 |
| Eugia Pharma | For profit | SYN | Mar 29, 2012 |
| Fresenius | For profit | NDA2 | Aug 25, 2014 |
| Fresenius | For profit | MKTG | Jun 13, 1994 |
| Fresenius | For profit | SYN | Sep 3, 1980 |
| Hikma | For profit | MKTG | Aug 1, 1994 |
| Hikma | For profit | SYN | Sep 16, 1986 |
| Hospira | For profit | NDA2 | Jan 15, 1980 |
| Hospira | For profit | MKTG | Nov 7, 1988 |
| ICU Medical Inc | For profit | MKTG | Aug 13, 1975 |
| ICU Medical Inc | For profit | NDA2 | Aug 13, 1975 |
| International Medication | For profit | MKTG | May 9, 2018 |
| Lotus Pharmaceutical | For profit | MKTG | Apr 23, 2021 |
| Lukare Medical | For profit | MKTG | Sep 27, 1996 |
| Lukare Medical | For profit | NDA2 | Sep 27, 1996 |
| Lutipold | For profit | MKTG | Jul 27, 2017 |
| Medefil | For profit | MKTG | May 1, 2019 |
| Miles | For profit | NDA2 | — |
| Mylan | For profit | MKTG | May 15, 1992 |
| Mylan | For profit | SYN | Mar 29, 2012 |
| Nestle | For profit | NDA2 | Oct 28, 1981 |
| Norbrook | For profit | MKTG | May 9, 1986 |
| Pharmachemie Bv | For profit | MKTG | Jan 8, 2010 |
| Pharmachemie Bv | For profit | SYN | Jul 8, 1988 |
| Pharmacia & Upjohn | For profit | MKTG | Aug 23, 1991 |
| Sagent Pharmaceuticals, Inc. | For profit | MKTG | Aug 9, 2018 |
| Sandoz | For profit | MKTG | Mar 31, 2009 |
| Sandoz | For profit | SYN | Mar 31, 2009 |
| Sankyo | For profit | MKTG | Jul 27, 2017 |
| Silvergate Pharmaceuticals | For profit | MKTG | Apr 25, 2017 |
| Somerset Pharmaceuticals | For profit | MKTG | Dec 17, 2024 |
| Strides Pharma Science | For profit | MKTG | Dec 7, 1953 |
| Sun Pharmaceuticals | For profit | MKTG | May 21, 2015 |
| West-Ward Pharmaceutical | For profit | MKTG | Sep 16, 1986 |
| Zydus Discovery DMCC | For profit | MKTG | Jan 13, 2017 |